Showing results (511-520 of 753) with videos related to
Sort By:
Pageof 76
Neuro-Oncology|November 19, 2022
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticityJamie A Dean, Shyam K Tanguturi, Daniel Cagney, et al.Neuro-Oncology|May 21, 2024
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncologyRifaquat Rahman, Diana D Shi, Zachary J Reitman, et al.Neuro-Oncology|January 23, 2019
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applicationsAdrienne Boire, Dieta Brandsma, Priscilla K Brastianos, et al.Journal of Neuro-Oncology|November 29, 2019
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastomaMartin van den Bent, Analia Azaro, Filip De Vos, et al.Journal of Neuro-Oncology|October 5, 2017
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab aloneNils D Arvold, Diana D Shi, Ayal A Aizer, et al.Plos One|June 22, 2012
DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissuesJustin M Craig, Natalie Vena, Shakti Ramkissoon, et al.Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.Neuro-Oncology|December 21, 2014
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KDaniel J Ma, Evanthia Galanis, S Keith Anderson, et al.Neuro-Oncology Practice|February 7, 2025
Glioma resource outreach with support: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patientsRachel Garcia Fox, Ugonma N Chukwueke, Timothy Sannes, et al.Neuro-Oncology|November 1, 2020
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trialsBenjamin M Ellingson, Matthew S Brown, Jerrold L Boxerman, et al.Pageof 76